Adapting clinical trial design for the era of personalized medicine
Personalized medicine aims to tailor prevention, diagnosis, and treatment to the unique biological traits, environmental conditions, and lifestyle patterns of each patient, and over the past decade this concept has gradually become part of standard practice, shaping how therapies are developed and how clinical trials are designed. Advances in genomics, data science, and digital health continue to propel this shift, while regulatory agencies and healthcare organizations adjust their approaches to support more precise, individualized, and patient-centered research models.Genomics and Multi-Omics as Foundational DriversThe steep drop in genome sequencing costs, paired with the expanding use of multi-omics approaches, has significantly transformed…
